Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 17
Smartphone sensors for evaluating COVID-19 fear in patients with cancer: a prospective study
Gabrielė Kasputytė, Gabrielė Jenciūtė, Nerijus Šakinis, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2
Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13
Impact of COVID-19 pandemic on older cancer patients: Proposed solution by the International Geriatric Radiotherapy Group
Nam P. Nguyen, Ulf Karlsson, David Lehrman, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6
Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
Yash Shah, Stephanie Kjelstrom, Diana Martinez, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3577-3588
Open Access | Times Cited: 6
Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis
Huanhuan Cao, Yufei Huang, Chun-Xiu Zhong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
Antonio Giovanni Solimando, Max Bittrich, Endrit Shahini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8746-8746
Open Access | Times Cited: 3
Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis
Xiaoming Li, Xia Yang, Zong Ning
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
COVID-19 vaccination outcomes in patients with a solid malignancy: Insights from extensive real-world data and propensity score matched analyses
G Dimitrov, Krassimir Kalinov, Trifon Valkov
American Journal of Infection Control (2023) Vol. 52, Iss. 6, pp. 678-682
Open Access | Times Cited: 2
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
Tong Li, Rui Song, Jingjie Wang, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 874-884
Open Access | Times Cited: 4
Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis
Kejia Li, Xia Yang, Hua Ye, et al.
Biomedical Reports (2024) Vol. 20, Iss. 5
Open Access
Cardiovascular Safety of COVID-19 Vaccination in Patients With Cancer: A Self-Controlled Case Series Study in Korea
Ji Hwa Ryu, Ahhyung Choi, Jieun Woo, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 24
Open Access
Clinical and Nutritional Aspects and Outcomes of Covid-19 in Cancer and Non-Cancer Pediatric Patients
Greice Milena Sant’Ana Reis, Heleni Aires Clemente, José Adaílton da Silva, et al.
Nutrition and Cancer (2024) Vol. 77, Iss. 2, pp. 179-187
Closed Access
How does geographical diversity shape vaccine efficacy?
Mohammad Abavisani, Bahareh Ansari, Negar Ebadpour, et al.
Clinical and Experimental Vaccine Research (2024) Vol. 13, Iss. 4, pp. 271-271
Open Access
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 9, pp. e10583-e10583
Open Access | Times Cited: 3
SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study
Fahimeh Safarnezhad Tameshkel, Shabnam Abedin Dargoush, Bahareh Amirkalali, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 1
COVID-19-related burnout reduces COVID-19 vaccination intention in cardiac patients: a cross-sectional study in Greece
Petros Galanis, Aglaia Katsiroumpa, Irène Vraka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Repercussões da pandemia da COVID-19 no cotidiano de pacientes oncológicos
Júlia Nogueira Mourão, Maria Luiza Vecchi Ferreira, Fernanda Morais de Sousa, et al.
Research Society and Development (2023) Vol. 12, Iss. 3, pp. e1312340323-e1312340323
Open Access | Times Cited: 1
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Marina A. Lyadova, Denis S. Fedorinov, Evgenia Kuzmina, et al.
Journal of Modern Oncology (2023) Vol. 25, Iss. 3, pp. 392-396
Open Access | Times Cited: 1
Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
Kyoungmin Lee, In Hae Park, Sang Cheul Oh, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 5558-5568
Open Access | Times Cited: 2
A year of experience with COVID‐19 in patients with cancer: A nationwide study
Mina Khosravifar, Sogol Koolaji, Negar Rezaei, et al.
Cancer Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Managing acute COVID-19 in immunocompromised pediatric patients
Federico Mercolini, Nicoletta Abram, Simone Cesaro
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 349-357
Closed Access
The Effects of the COVID-19 Pandemic in Oncology Patient Management
Mário Forrester, Luiza Breitenfeld, Miguel Castelo-Branco, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 9041-9041
Open Access
Page 1 - Next Page

Scroll to top